Gene: AGBL4
Official Full Name: AGBL carboxypeptidase 4provided by HGNC
Gene Summary: Predicted to enable metallocarboxypeptidase activity and tubulin binding activity. Predicted to be involved in C-terminal protein deglutamylation; defense response to virus; and protein side chain deglutamylation. Predicted to act upstream of or within several processes, including axonal transport of mitochondrion; positive regulation of ubiquitin-dependent protein catabolic process; and regulation of blastocyst development. Located in Golgi apparatus; centriole; and ciliary basal body. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA00140 | AGBL4 Knockout cell line (293T) | Human | AGBL4 | 1:3~1:6 | negative | Online Inquiry |
| KOA06239 | AGBL4 Knockout cell line (AC16) | Human | AGBL4 | 1:3-1:4 | negative | Online Inquiry |
| KOA21682 | AGBL4 Knockout cell line (BEAS-2B) | Human | AGBL4 | 1:3~1:4 | negative | Online Inquiry |
| KOA37128 | AGBL4 Knockout cell line (U-2932) | Human | AGBL4 | 1:2-1:4 | negative | Online Inquiry |
| KOA52533 | AGBL4 Knockout cell line (TPC-1) | Human | AGBL4 | 1:5-1:8 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.